Eureka Therapeutics
Phase 1/2Eureka Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative technology platforms that can access cancer-specific targets and harness the evolutionary power of T cells for the treatment of solid tumors and other malignancies.
Founded
2006
Focus
AntibodiesBiologicsCell & Gene Therapy
About
Eureka Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative technology platforms that can access cancer-specific targets and harness the evolutionary power of T cells for the treatment of solid tumors and other malignancies.
Funding History
3Total raised: $125M
Series C$60MMorningside Venture InvestmentsJun 15, 2021
Series B$45MMorningside Venture InvestmentsJun 15, 2018
Series A$20MMorningside Venture InvestmentsJun 15, 2015
Company Info
TypePrivate
Founded2006
LocationEmeryville, United States
StagePhase 1/2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile